regarding nbme form 13 block 2 q23
Basically, pregnant woman, G2P1, coming in for routine 18-week visit. Her 5M son has Parvo B19. Management?
A. Routine AFP because it's the routine second trimester visit
B. Serum specific IgM and IgG because concern for parvoB19 infection
The answer is B, with an explanation that Parvo B19 is concerning in second OR third trimester for its ability to cause fetal anemia -> hydrops fetalis.
But, from Anking:
"What is the management of a pregnant patient with a positive antibody testing of parvovirus B19 < 20 weeks of gestation?
{{c1::Reassurance}}
--
There is a small risk for fetal loss
No proven risk of anomaly"
So, what am I to believe here?
Doing this after the "scleroderma woman with malnutrition and 3 of 9 sigecaps -> sertraline instead of an appetite stimulant" and thoroughly questioning my knowledge from anking/uworld...